Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for ...

Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact on public health is really unprecedented in modern times, perhaps only upstaged by ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

Named by the Evening Standard as one of the top 100 people shaping London in 2025, Professor David Nutt has authored over 500 research papers and more than 30 books. One of the world’s foremost ...

Nick Padlo’s addiction to alcohol and drugs didn’t happen overnight. “I was using them as a tool to cope with depression and anxiety,” says the recovered addict and founder of Sophros Recovery in ...

Ana Clara Bobadilla receives funding from the National Institute on Drug Abuse and the Brain & Behavior Research Foundation. Everyday human behavior is guided and shaped by the search for rewards.

Athletes, actors, politicians, and others often develop substance abuse disorders and some die from drug-related deaths. At the same time, their life history, drug use, and risk-taking shows the rest ...